Sandra Van Wetering
COO
Medicine
Tanner Health System
Sweden
Biography
Sandra van Wetering is responsible for the day to day management of all operational activities related to the company’s technology, and as such is responsible for the proper execution of product development, manufacturing, regulatory and clinical activities, from proof of principle to approved DCOne®-based therapeutic products (US/EU). Sandra holds a PhD in immunology and worked for more than 10 years in academia where she obtained broad knowledge of immunological techniques, cell culture and tissue engineering. Before joining DCPrime in 2007, she worked for 3 years as a scientist at Pharming N.V. where she headed the bio-immunological group and was responsible for both non-clinical and clinical assay development. Furthermore, she was closely involved in new target identification, and a member of the project group responsible for filing products for EMA/FDA approval.
Research Interest
MEDICINE
